Biomarker, Imaging, and Clinical Factors Associated With Overt and Covert Stroke in Patients With Atrial Fibrillation.

Publication

Biomarker, Imaging, and Clinical Factors Associated With Overt and Covert Stroke in Patients With Atrial Fibrillation.

Journal Paper/Review - Aug 7, 2023

De Marchis Gian Marco, Krisai Philipp, Werlen Laura, Sinnecker Tim, Aeschbacher Stefanie, Dittrich Tolga, Polymeris Alexandros A, Coslovksy Michael, Blum Manuel R, Rodondi Nicolas, Reichlin Tobias, Moschovitis Giorgio, Wuerfel Jens, Lyrer Philippe A, Fischer Urs, Conen David, Kästner Peter, Ziegler Andreas, Osswald Stefan, Kühne Michael, Bonati Leo H, Swiss-AF investigators

Citation

De Marchis G, Krisai P, Werlen L, Sinnecker T, Aeschbacher S, Dittrich T, Polymeris A, Coslovksy M, Blum M, Rodondi N, Reichlin T, Moschovitis G, Wuerfel J, Lyrer P, Fischer U, Conen D, Kästner P, Ziegler A, Osswald S, Kühne M, Bonati L, Swiss-AF investigators. Biomarker, Imaging, and Clinical Factors Associated With Overt and Covert Stroke in Patients With Atrial Fibrillation. Stroke 2023

Type

Journal Paper/Review (English)

Journal

Stroke 2023

Publication Date

Aug 7, 2023

Issn Electronic

1524-4628

Brief description/objective

Atrial fibrillation is a major risk factor for stroke and silent brain infarcts. We studied whether a multimodal approach offers additional insights to the CHADS-VASc score in predicting stroke or new brain infarcts on magnetic resonance imaging (MRI) over a 2-year follow-up.